JiangXi Tianxin Pharmaceutical Co., Ltd.SSE: 603235

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by JiangXi Tianxin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

JiangXi Tianxin Pharmaceutical Co., Ltd. has announced a performance briefing for the year and first quarter of the following year. The briefing is scheduled to take place in May and will be conducted online. Investors will have the opportunity to submit questions prior to the event for discussion during the briefing. The company aims to provide insights into its financial performance and address investor concerns during this session.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

JiangXi Tianxin Pharmaceutical Co., Ltd. on 6ix

Earlier from JiangXi Tianxin Pharmaceutical

Later from JiangXi Tianxin Pharmaceutical

All JiangXi Tianxin Pharmaceutical news releases